These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9702731)

  • 1. A beta peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer's disease pathogenesis.
    Sommer B; Staufenbiel M
    Mol Psychiatry; 1998 Jul; 3(4):284-6, 282-3. PubMed ID: 9702731
    [No Abstract]   [Full Text] [Related]  

  • 2. Deposits of amyloid beta protein in the central nervous system of transgenic mice.
    Wirak DO; Bayney R; Ramabhadran TV; Fracasso RP; Hart JT; Hauer PE; Hsiau P; Pekar SK; Scangos GA; Trapp BD
    Science; 1991 Jul; 253(5017):323-5. PubMed ID: 1857970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta42, presenilins, and Alzheimer's disease.
    Iwatsubo T
    Neurobiol Aging; 1998; 19(1 Suppl):S11-3. PubMed ID: 9562460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer's disease due to presenilin mutations].
    Tabira T
    Nihon Rinsho; 2004 Jan; 62 Suppl():90-4. PubMed ID: 15011327
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of an 'Amyloid Only' Transgenic (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) Mouse Model of Alzheimer's Disease.
    Finnie GS; Gunnarsson R; Manavis J; Blumbergs PC; Mander KA; Edwards S; Van den Heuvel C; Finnie JW
    J Comp Pathol; 2017 May; 156(4):389-399. PubMed ID: 28431735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of V-ATPase function defects in pathogenesis of Alzheimer's disease.
    Zhao ZW; Yuan Z; Zhao DQ; Wang ZW; Zhu FQ; Luan P
    CNS Neurosci Ther; 2018 Sep; 24(9):837-840. PubMed ID: 29761665
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.
    Kuo YM; Crawford F; Mullan M; Kokjohn TA; Emmerling MR; Weller RO; Roher AE
    Mol Med; 2000 May; 6(5):430-9. PubMed ID: 10952022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.
    Belkacemi A; Ramassamy C
    Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta conformational change is central to Alzheimer's disease.
    Holtzman DM
    Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models.
    Lehman EJ; Kulnane LS; Lamb BT
    Neurobiol Aging; 2003 Sep; 24(5):645-53. PubMed ID: 12885572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.
    Yankner BA; Lu T
    J Biol Chem; 2009 Feb; 284(8):4755-9. PubMed ID: 18957434
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
    Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
    Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.